ZNF207

Across TCGA pan-cancer cohorts, ZNF207 RNA differs between tumor and matched normal tissue in 16 of 18 cancer types tested, making tumor–normal expression one of ZNF207’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF207 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF207 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC, COAD, and BLCA are the cancer types where ZNF207 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF207 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.454	<.001	12	view →
COAD	Female	All	+0.721	<.001	11	view →
BLCA	Male	III,IV	+0.699	<.001	11	view →
KIRP	All	II,III,IV	+0.678	<.001	11	view →
LUAD	Male	All	+0.582	<.001	11	view →
HNSC	Male	All	+0.562	<.001	10	view →
LIHC	Female	II,III,IV	+1.142	<.001	9	view →
STAD	All	II,III,IV	+0.684	<.001	8	view →
LUSC	Female	All	+0.629	<.001	7	view →
READ	All	All	+0.468	<.001	7	view →
BRCA	All	III,IV	+0.449	<.001	6	view →
CHOL	Male	All	+2.195	<.001	5	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 16 lineages.

ZNF207–KIRC

Open the KIRC breakdown →